title: End stage renal disease and prophylactic intracavitary interferon.
authors.affiliation: Department of Nephrology, Hospital Ramón y Cajal, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Pascual
authors.forename: C
authors.initials: C
authors.lastname: Quereda
authors.forename: F J
authors.initials: FJ
authors.lastname: Burgos
authors.forename: F
authors.initials: F
authors.lastname: Liaño
authors.forename: F
authors.initials: F
authors.lastname: Mampaso
authors.forename: B
authors.initials: B
authors.lastname: Frutos
authors.forename: J
authors.initials: J
authors.lastname: Ortuño
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000209:etiology*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha